Patent · US Active

Methods of protecting the sequence of an antibody conjugate from being determined

US11730821B2 · kind B2 · utility

0Cited by

14References

18Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Hartmut Duefel · Schlehdorf, DE
Uwe Kobold · Wielenbach, DE
Andreas Leinenbach · Oberhausen, DE

Key dates

Filing date	Sep 21, 2022
Grant date	Aug 22, 2023
Priority date	—
Expiry date	Sep 21, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2458/15
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure is directed at an antibody conjugate having an antibody and a tag, wherein one or more element(s) present in the antibody exhibit an isotope ratio which differs from the naturally occurring isotope ratio of the one or more element(s), wherein the amount of the isotope which is less-common in nature, is increased to at least 4% of the atoms of the respective element in the antibody, as well as uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.